glp-1 drugs and dementia Alzheimer's Disease: Research on Neuroprotective Potential Prevention of Dementia with GLP-1
Description
Therefore, anti-inflammatory and neuroprotection effects might be exerted through inhibiting NF-B and MAPKs signaling pathways (88)
(2024, December 15)
Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Ko MW, Chang SC, Ridha MA, et al
Rubino D., Abrahamsson N., Davies M., et al., Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial, Journal of the American Medical Association 325 (2021): 14141425
